HLA-A and neoplasm: A beneficial effect of local tumor control was observed in all animals receiving STEAP1130/HLA-A*02:01-specific TCR transgenic T cells (tgCD4, tgCD8, and tgCD4 plus tgCD8 T cells) in comparison to mice receiving non-specific PBMC.